Andrew Orth
Vermogen: 24 M $ op 30-09-2026
Vermogen: 24 M $ op 30-09-2026
Mr. Andrew C.
Orth is a President, Chief Executive Officer & Director at City Therapeutics, Inc. He is on the Board of Directors at City Therapeutics, Inc. Mr. Orth was previously employed as a Chief Commercial Officer by Krystal Biotech, Inc. and a Senior Vice President & Head-US Busines by Alnylam Pharmaceuticals, Inc. He received his undergraduate degree from the University of Wisconsin and an MBA from Johnson Graduate School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
2,06% | 19-10-2026 | 1.063.154 ( 2,06% ) | 24 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 02-08-2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2016 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau